Literature DB >> 11001881

Analysis of the CC chemokine receptor 3 gene reveals a complex 5' exon organization, a functional role for untranslated exon 1, and a broadly active promoter with eosinophil-selective elements.

N Zimmermann1, B L Daugherty, J L Kavanaugh, F Y El-Awar, E A Moulton, M E Rothenberg.   

Abstract

To understand the regulation of CC chemokine receptor 3 (CCR3) expression, its gene structure and promoter have been characterized. The CCR3 gene contains 4 exons that give rise to multiple messenger RNA (mRNA) species by alternative splicing. Exon 1 is present in all transcripts, whereas exon 2 or 3 is present at low frequency (< 10%). Exon 4 contains the open reading frame and 11 bp of the 5' untranslated region. Northern analysis revealed 4 species of CCR3 mRNA. Direct sequencing revealed that the first 1 kb of the promoter and exon 1 contained only one mutation in 19 individuals, indicating that the CCR3 promoter and exon 1 are conserved between individuals. The first 1.6 kb of the 5' flanking region of exon 1 contained promoter elements including a TATA box and motifs for myeloid transcription factors and had strong promoter activity in eosinophilic, lymphoid, myeloid, and respiratory epithelial cell lines. Deletion analysis revealed differential regulation of the CCR3 promoter in eosinophilic and epithelial cells suggesting the presence of lineage-specific elements. Interestingly, exon 1 enhanced the activity of the promoter and this effect was especially prominent in eosinophilic cells. Thus, the human CCR3 gene has a complex 5' exon structure, a conserved promoter with strong activity in multiple cell types, and a functional 5' untranslated exon.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11001881

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Cloning and functional characterization of the human fractalkine receptor promoter regions.

Authors:  Alexandre Garin; Philippe Pellet; Philippe Deterre; Patrice Debré; Christophe Combadière
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

Review 2.  Biology of the eosinophil.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

3.  Ablation of type I hypersensitivity in experimental allergic conjunctivitis by eotaxin-1/CCR3 blockade.

Authors:  Dai Miyazaki; Takao Nakamura; Masaharu Ohbayashi; Chuan Hui Kuo; Naoki Komatsu; Keiko Yakura; Takeshi Tominaga; Yoshitsugu Inoue; Hidemitsu Higashi; Meguru Murata; Shuzo Takeda; Atsuki Fukushima; Fu-Tong Liu; Marc E Rothenberg; Santa Jeremy Ono
Journal:  Int Immunol       Date:  2009-01-15       Impact factor: 4.823

Review 4.  The Eosinophil in Health and Disease: from Bench to Bedside and Back.

Authors:  Wei Liao; Hai Long; Christopher Chia-Chi Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

5.  Eosinophil development, regulation of eosinophil-specific genes, and role of eosinophils in the pathogenesis of asthma.

Authors:  Tae Gi Uhm; Byung Soo Kim; Il Yup Chung
Journal:  Allergy Asthma Immunol Res       Date:  2011-11-25       Impact factor: 5.764

6.  CpG methylation at GATA elements in the regulatory region of CCR3 positively correlates with CCR3 transcription.

Authors:  Tae Gi Uhm; Seol Kyung Lee; Byung Soo Kim; Jin Hyun Kang; Choon Sik Park; Tai Youn Rhim; Hun Soo Chang; Do Jin Kim; Il Yup Chung
Journal:  Exp Mol Med       Date:  2012-04-30       Impact factor: 8.718

7.  Analysis of the CCR3 promoter reveals a regulatory region in exon 1 that binds GATA-1.

Authors:  Nives Zimmermann; Jessica L Colyer; Laura E Koch; Marc E Rothenberg
Journal:  BMC Immunol       Date:  2005-04-04       Impact factor: 3.615

Review 8.  Pushing the limits of the scanning mechanism for initiation of translation.

Authors:  Marilyn Kozak
Journal:  Gene       Date:  2002-10-16       Impact factor: 3.688

9.  Roles of RUNX1 and PU.1 in CCR3 Transcription.

Authors:  Su-Kang Kong; Byung Soo Kim; Sae Mi Hwang; Hyune Hwan Lee; Il Yup Chung
Journal:  Immune Netw       Date:  2016-06-17       Impact factor: 6.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.